Hackensack Meridian Children’s Health Pediatric Oncology
Offering cutting-edge treatment protocols and hands-on care from newborns to young adults.
Hackensack Meridian Children’s Health pediatric oncologists are leading cutting-edge clinical research while providing diagnosis and treatment of leukemia, lymphoma, neuroblastoma, bone, brain and kidney tumors, as well as rare tumor types.
Hackensack Meridian Children’s Health Study Assesses Barriers to Sperm Banking in Young Males with High-Risk Acute Lymphoblastic Leukemia
Joseph M. Sanzari Children’s Hospital researchers survey pediatric oncologists on offering sperm banking to newly-diagnosed young men with leukemia
Romiplostim Supports Platelet Counts in Pediatric Patients Treated for Solid Tumors in Research Study
Hackensack University Medical Center physicians helped show drug effectiveness addressing the potential chemotherapy side effect of thrombocytopenia
Joseph M. Sanzari Children’s Hospital Shows PET Value in Pediatric Nodular Lymphocyte-Predominant Hodgkin Lymphoma Outcomes
Children’s Oncology Group study addresses lack of published data on PET use in patients with nLPHL
HLA-DRB1 HED Predicts Improved Survival after Allogeneic Stem Cell Transplant
HLA-DRB1 HED also associated with lower risk of relapse following transplantation in study
Joseph M. Sanzari Children’s Hospital Conducts Research on Childhood Cancer Survivorship
Program aimed at increasing survival rates and addressing unique challenges
Early Phase Clinical Trials Provide New Hope for Children and Families Facing Pediatric Cancer
Researchers participating in 25 clinical trials for brain tumors, blood cancers, hematologic disorders, and solid tumors
Hackensack Meridian Children’s Health Establishes Focus on Cancer Survivorship
Multidisciplinary approach includes specialized Cure and Beyond clinic and research studies
Pediatric Hematologist-Oncologist Works to Standardize Premedication for Blood Product Transfusions
More judicious use of premedication does not result in increased reactions
Joseph M. Sanzari Children’s Hospital Establishes Adolescent and Young Adult Program for Patients with Cancer
Program aimed at increasing survival rates and addressing unique challenges
Pilot Study Tests Safety of Genomic-Guided Induction Therapy for High-Risk Neuroblastoma
Study also tests addition of maintenance drug to help prevent relapse
Study Examines Survival of Adolescents with Hodgkin Lymphoma in Oncology Trials
Pediatric hematologist/oncologist has lead role in clinical research on Hodgkin lymphoma
Joseph M. Sanzari Children’s Hospital Studies New Combination Therapy to Treat Rare, Aggressive Cancer of the Central Nervous System
Hospital is the only site in New Jersey participating in international clinical trial
Joseph M. Sanzari Children’s Hospital Launches Cryopreservation, New Jersey’s Only Fertility Preservation Program
Program offers hope to young patients who undergo cancer treatment that may affect fertility
Research Studies Impact of Chemotherapy-Induced Thrombocytopenia on Pediatric Cancer Treatment
Complication may require platelet transfusions and treatment modifications
New Hematology-Oncology Specialist Joins Joseph M. Sanzari Children’s Hospital
Dr. Camacho-Bydume brings expertise in treatment of blood cancers in children
New Pediatric Hematology-Oncology Specialist to Join Hospital
Dr. Degliuomini’s clinical and research focus is on the effects of children’s cancer treatment on platelets
Pediatric Oncologist/Hematologist Co-Authors Article Accepted for Publication in Leukemia & Lymphoma
Global working group addresses rare subtype of Hodgkin lymphoma